The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL

[1]  R. Netea-Maier,et al.  Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly , 2015, Pituitary.

[2]  M. Fouad,et al.  Health‐related quality of life in lung cancer survivors: Latent class and latent transition analysis , 2015, Cancer.

[3]  K. Wijma,et al.  Prevalence of body dysmorphic disorder among Swedish women: a population-based study. , 2015, Comprehensive psychiatry.

[4]  S. Webb,et al.  Health-related quality of life in pituitary diseases. , 2015, Endocrinology and metabolism clinics of North America.

[5]  P. Kadıoğlu,et al.  Impact of treatment satisfaction on quality of life of patients with acromegaly , 2014, Pituitary.

[6]  J. Chung,et al.  An assessment of the impact of type 2 diabetes on the quality of life based on age at diabetes diagnosis , 2014, Acta Diabetologica.

[7]  M. Cusimano,et al.  Endoscopic Transphenoidal Surgery for Acromegaly Improves Quality of Life , 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  Zhen Wang,et al.  Surgical interventions and medical treatments in treatment-naïve patients with acromegaly: systematic review and meta-analysis. , 2014, The Journal of clinical endocrinology and metabolism.

[9]  Lisa G. Smith,et al.  Comparison of younger and older breast cancer survivors and age‐matched controls on specific and overall quality of life domains , 2014, Cancer.

[10]  S. Melmed,et al.  Immune modulation in humans: implications for type 1 diabetes mellitus , 2014, Nature Reviews Endocrinology.

[11]  Z. Efstathiadou,et al.  Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? , 2014, Endocrine.

[12]  C. Rhodes,et al.  Patient perspectives on the impact of acromegaly: results from individual and group interviews , 2014, Patient preference and adherence.

[13]  J. Koivukangas,et al.  Long-Term Health-Related Quality of Life of Surgically Treated Pituitary Adenoma Patients: A Descriptive Study , 2012, ISRN endocrinology.

[14]  J. Honegger,et al.  Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. , 2012, European journal of endocrinology.

[15]  K. Chihara,et al.  Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. , 2012, Endocrine journal.

[16]  J. Romijn,et al.  Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly. , 2011, The Journal of clinical endocrinology and metabolism.

[17]  Y. Aydın,et al.  Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly , 2011, Pituitary.

[18]  S. Ezzat,et al.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[19]  B. Wolffenbuttel,et al.  Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. , 2011, European journal of endocrinology.

[20]  M. Kosinski,et al.  Validation testing of a three-component model of Short Form-36 scores. , 2011, Journal of clinical epidemiology.

[21]  H. Middelkoop,et al.  Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. , 2010, The Journal of clinical endocrinology and metabolism.

[22]  P. Chanson,et al.  A consensus on criteria for cure of acromegaly. , 2010, The Journal of clinical endocrinology and metabolism.

[23]  A. Gregor,et al.  Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  H. Wittchen,et al.  Prevalence of mental disorders in acromegaly: a cross‐sectional study in 81 acromegalic patients , 2009, Clinical endocrinology.

[25]  S. Melmed,et al.  Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension , 2009, Pituitary.

[26]  P. Chanson,et al.  Guidelines for acromegaly management: an update. , 2009, The Journal of clinical endocrinology and metabolism.

[27]  X. Badia,et al.  Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  G. Gamble,et al.  A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. , 2008, European journal of endocrinology.

[29]  J. Romijn,et al.  Previous radiotherapy negatively influences quality of life during 4 years of follow‐up in patients cured from acromegaly , 2008, Clinical endocrinology.

[30]  P. Caron,et al.  Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. , 2008, European journal of endocrinology.

[31]  J. Mockel,et al.  AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. , 2007, European journal of endocrinology.

[32]  B. Velkeniers,et al.  Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly. , 2007, European journal of endocrinology.

[33]  X. Badia,et al.  Treatment of acromegaly improves quality of life, measured by AcroQol , 2007, Clinical endocrinology.

[34]  S. Melmed.  Medical progress: Acromegaly. , 2006, The New England journal of medicine.

[35]  Tien-Chun Chang,et al.  Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. , 2006, European journal of endocrinology.

[36]  X. Badia,et al.  Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. , 2006, European journal of endocrinology.

[37]  E. Christ,et al.  Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL) , 2005, Clinical endocrinology.

[38]  X. Badia,et al.  Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. , 2005, The Journal of clinical endocrinology and metabolism.

[39]  J. Romijn,et al.  Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. , 2005, The Journal of clinical endocrinology and metabolism.

[40]  V. Esposito,et al.  The long‐term efficacy of conventional radiotherapy in patients with GH‐secreting pituitary adenomas , 2005, Clinical endocrinology.

[41]  J. Romijn,et al.  Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. , 2004, The Journal of clinical endocrinology and metabolism.

[42]  X. Badia,et al.  Acromegaly Quality of Life Questionnaire (ACROQOL) a new health‐related quality of life questionnaire for patients with acromegaly: development and psychometric properties , 2002, Clinical endocrinology.

[43]  D. Harris,et al.  Prevalence of concern about physical appearance in the general population. , 2001, British journal of plastic surgery.

[44]  S. Fukuhara,et al.  Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. , 1998, Journal of clinical epidemiology.

[45]  L. Cronbach.  Coefficient alpha and the internal structure of tests , 1951 .

[46]  P. Marik,et al.  A Descriptive Study , 2015 .

[47]  S. Yamada,et al.  Rapid growth hormone measurement during transsphenoidal surgery: analysis of 252 acromegalic patients. , 2012, Neurologia medico-chirurgica.

[48]  G. Vitale,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(1):84–90 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-0240 Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Stud , 2022 .

[49]  J. Nunnally.  Psychometric Theory (2nd ed), New York: McGraw-Hill. , 1978 .